Targeting CD2 for immunotherapy: Results of a phase 1 trial with a LFA-3/IgG Fe fusion protein.

被引：0
|
作者：
Magilavy, D
Norman, P
Majeau, G
Knox, S
Winkler, G
MacLellan, S
Sartori, L
Cooney, M
Meier, W
Hochman, P
Rogge, M
机构：
[1] Biogen Inc, Cambridge, MA 02142 USA
[2] UMDS, Guys Hosp, London, England
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1998年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：682 / 682
页数：1
相关论文
共 50 条
  • [1] Targeting CD2 for immunotherapy: Results of a phase 1 trial with a LFA-3/IgG Fc fusion protein.
    Magilavy, D
    Norman, P
    Majeau, G
    Knox, S
    Winkler, G
    MacLellan, S
    Sartori, L
    Rogge, M
    Cooney, M
    Meier, W
    Hochman, P
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 873 - 873
  • [2] Alefacept: Amevive, BG 9273, human LFA-3/Igg fusion protein, LFA 3, LFA 3 TIP, LFA 3/CD2, LFA-3/Igg fusion protein, LFA3TIP, recombinant LFA-3/Igg1 human fusion protein, recombinantly engineered LFA-1/Igg1 human fusion protein
    不详
    Drugs in R & D, 2002, 3 (1) : 21 - 24
  • [3] A computer model of the LFA-3/CD2 complex
    Nuallain, BO
    Grant, GH
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1998, 26 (01) : S44 - S44
  • [4] PURIFICATION AND CD2 BINDING FUNCTION OF LFA-3
    DUSTIN, M
    SANDERS, M
    SHAW, S
    SPRINGER, T
    FEDERATION PROCEEDINGS, 1987, 46 (04) : 1498 - 1498
  • [5] DIRECT EVIDENCE THAT LFA-3 IS A LIGAND FOR THE CD2 RECEPTOR
    HERRMANN, SH
    TAKAI, Y
    ROSENSTEIN, Y
    REED, ML
    BURAKOFF, SJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 270 - 270
  • [6] DIRECT EVIDENCE THAT LFA-3 IS A LIGAND FOR THE CD2 RECEPTOR
    TAKAI, Y
    ROSENSTEIN, Y
    REED, ML
    BURAKOFF, SJ
    HERRMANN, SH
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 1052 - 1052
  • [7] NOVEL HUMAN LYMPHOCYTE-T SUBSETS DEFINED BY HIGH EXPRESSION OF CD2 AND LFA-3 VERSUS LOW EXPRESSION OF CD2 AND LFA-3
    SANDERS, ME
    SHARROW, S
    STEPHANY, D
    SPRINGER, TA
    SHAW, S
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 1053 - 1053
  • [8] T-CELL ACTIVATION BY LFA-3 AND CD2 ANTIBODIES
    DUSTIN, ML
    OLIVE, D
    SPRINGER, TA
    FASEB JOURNAL, 1988, 2 (05): : A1239 - A1239
  • [9] FUNCTIONAL CD2 MUTANTS UNABLE TO BIND TO, OR BE STIMULATED BY, LFA-3
    WOLFF, HL
    BURAKOFF, SJ
    BIERER, BE
    JOURNAL OF IMMUNOLOGY, 1990, 144 (04): : 1215 - 1220
  • [10] Low affinity binding of an LFA-3/IgG1 fusion protein to CD2+ T cells is independent of cell activation
    Majeau, GR
    Whitty, A
    Yim, K
    Meier, W
    Hochman, PS
    CELL ADHESION AND COMMUNICATION, 1999, 7 (03) : 267 - 279
12345